|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 51/08 | |
| A61K 31/7056 | |||
| A61K 31/265 | |||
| A61K 31/7028 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61K 101/02 | |||
| A61K 103/10 | |||
| A61K 103/20 |
| (11) | Number of the document | 2729183 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12733134.6 |
| Date of filing the European patent application | 2012-07-06 | |
| (97) | Date of publication of the European application | 2014-05-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/063326 |
| Date | 2012-07-06 |
| (87) | Number | WO 2013/007660 |
| Date | 2013-01-17 |
| (30) | Number | Date | Country code |
| 11173281 | 2011-07-08 | EP |
| (72) |
MAINA-NOCK, Theodosia, GR
NOCK, Berthold Artur, GR
DE JONG, Marion, NL
|
| (73) |
Advanced Accelerator Applications USA, Inc.,
2711 Centerville Road, Suite 400, Wilmington, DE 19808,
US
|
| (54) | ENHANCED IN VIVO TARGETING OF RADIOLABELLED PEPTIDES WITH THE MEANS OF ENZYME INHIBITORS |
| ENHANCED IN VIVO TARGETING OF RADIOLABELLED PEPTIDES WITH THE MEANS OF ENZYME INHIBITORS |